Psychologists in Montana - Medicare Status, Address, Contact

289 Psychologists found. Showing 281 - 289

Burket Kniveton, LCPC CANDIDATE Psychologist - Counseling Medicare: Not Enrolled in Medicare Practice Location: 100 2nd St E, Whitefish, MT 59937 Phone: 406-499-2241

Kristina Johnson, PSYD TRAINEE Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 144 2nd St W Unit A, Whitefish, MT 59937 Phone: 520-780-8558

Dr. Timothy Scott Corson, PSY.D. Psychologist - Clinical Medicare: Accepting Medicare Assignments Practice Location: 121 Central Ave, Whitefish, MT 59937 Phone: 406-885-1158

Dr. David Joseph Mahoney, PHD Psychologist - Counseling Medicare: Not Enrolled in Medicare Practice Location: 100 2nd St E, Whitefish, MT 59937 Phone: 406-257-1731

Dr. Sara Boilen, PSYD Psychologist Medicare: Medicare Enrolled Practice Location: 144a 2nd St W, Whitefish, MT 59937 Phone: 406-662-1771

Samantha Kinkaid, PHDC, MA Psychologist Medicare: Not Enrolled in Medicare Practice Location: 309 Wisconsin Ave, Whitefish, MT 59937 Phone: 406-304-5446

Victoria Lynne Creighton, PSYD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 100 2nd St E, Whitefish, MT 59937 Phone: 406-212-9014

Dr. Jordan Fiorillo Scotti, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 144 2nd Street, Whitefish, MT 59937 Phone: 406-298-5728

Dr. Jason Schwenker, PSY.D. Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 14 2nd St W Ste 3, Whitefish, MT 59937 Phone: 406-818-5442    Fax: 406-818-5212

News Archive

Forbes.com interviews CEO of GeckoSystems

GeckoSystems Intl. Corp. (PINKSHEETS: GCKO) (http://www.geckosystems.com/) announced today that they are very pleased with the recent press coverage they have received from Forbes.com and other notable online authors. GeckoSystems is a dynamic leader in the emerging mobile robotics industry revolutionizing their development and usage with "Mobile Robot Solutions for Safety, Security and Service™."

Merck, Sinopharm sign statement of mutual intent for cooperation on HPV vaccine

Merck, known outside the U.S. and Canada as MSD, and Sinopharm today announced the signing of a statement of mutual intent. Under the statement, Sinopharm and Merck will cooperate on HPV vaccine and other mutually-selected vaccine products in China, and will also discuss the potential for promoting and marketing Merck's pharmaceutical products in China.

A Texas-sized Medicaid deal

KUHF's Carrie Feibel, reporting as part of a partnership with Kaiser Health News, NPR and KUHF, writes: "The deal that federal regulators struck with Texas this week to expand managed care coverage for the poor allows both Gov. Rick Perry, a Republican presidential contender, and a Democratic White House to claim victory for their very different healthcare agendas."

Study finds arsenic improves survival rate in APL patients

Arsenic, a toxic compound with a reputation as a good tool for committing homicide, has a significant positive effect on the survival of patients with acute promyelocytic leukemia (APL), when administered after standard initial treatment, according to a new, multi-center study led by a researcher at Wake Forest University Baptist Medical Center.

XOMA reaches enrollment goal of 325 patients for Phase 2b clinical trial of XOMA 052

XOMA Ltd., a leader in the discovery and development of therapeutic antibodies, announced that it has reached the enrollment goal of 325 patients for its Phase 2b dose-ranging clinical trial of XOMA 052, and that it expects patient enrollment to close in July 2010, with top-line results available in the first quarter of 2011. XOMA 052 is a therapeutic antibody candidate that inhibits the pro-inflammatory cytokine interleukin-1 beta (IL-1 beta) which drives the inflammatory cause of Type 2 diabetes.

Read more Medical News

› Verified 2 days ago

• «
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15(current)